Sort
39,280 grants matching “leukemia”
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
$748,641Robert K Bradley · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
A Combination Therapy Approach to Treating Drug Resistant Fungal Infections
$748,540Mitchell W Mutz · Amplyx Pharmaceuticals, Inc. · R44 · FY2014 · AI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
$748,425Andrew G Myers · Harvard University · R01 · FY2020 · CA
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
$748,425Andrew G Myers · Harvard University · R01 · FY2017 · CA
DNA Sequencing and Digital Gene Expression Core
$748,221Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Mitigating Hematologic Adverse Events in Patients with Myeloid Malignancies: A Novel Causal Artificial Intelligence Approach
$748,104Kun-Hsing Yu · Harvard Medical School · R01 · FY2025 · HL
Graft-versus-Host Disease: Local Maintenance by Tissue Resident Progenitor T cells
$747,995Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
NIH Myeloid Malignancy Program
$747,993Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Clinical Development of Novel Drugs for Children with Refractory Cancers
$747,962Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Bimodal gene editing strategy for HIV/AIDS cure in non-human primates
$747,950Tricia Helen Burdo · Temple Univ Of The Commonwealth · R56 · FY2019 · AI
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukemia
$747,876Smita Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL
$746,950Columbia University Health Sciences · P01 · FY2001 · CA
Role of Natural Pseudotyping with Other Viruses in HIV Transmission
$746,900James E.k Hildreth · University Of California At Davis · DP1 · FY2013 · AI
Wellbeing and Health Among Low Vision and Blind Youth
$746,801Adam Thomas Schmidt · Texas Tech University · R01 · FY2025 · EY
Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation
$746,773Edmund K. Waller · Emory University · R01 · FY2022 · AI
Treatment-Related Cardiotoxicity in Children with Relapsed Acute Myeloid Leukemia - Natural History, Occurrence and Implications
$746,751Kelly Diringer Getz · University Of Pennsylvania · R01 · FY2023 · HL
Human Monoclonal Antibodies Against Cancer
$746,707Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$746,370Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE
Eukaryotic Ribosome Assembly
$746,343Arlen W Johnson · University Of Texas At Austin · R35 · FY2023 · GM
Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics
$746,337Alexander Sparreboom · Ohio State University · R01 · FY2025 · HL
The physiological and molecular function of choline transport in health and metabolic disease
$746,070Kivanc Birsoy · Rockefeller University · R01 · FY2024 · DK
Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos
$745,989Adam De Smith · University Of Southern California · R01 · FY2022 · CA
Center for Big Data in Translational Genomics
$745,942David H Haussler · University Of California Santa Cruz · U54 · FY2015 · HG
Integrated Multi-Scale Analysis of Tumor and Host Response to Therapy
$745,852Shan X. Wang · University Of Southern California · U54 · FY2010 · CA
Fluorescence-based sequence-specific imaging of RNA modifications
$745,796Ling Tian · Mediomics, Llc · R44 · FY2024 · GM